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Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has resulted in over 11.6 million cases 
and 538,000 deaths as of July 7, 2020.1 The US is the worst-affected country, with more than 2.9 million 
cases.1 Evidence is limited regarding transmission risk, clinical presentation, and consequences of SARS-
CoV-2 among neonates of infected mothers. Risk of vertical transmission appears to be low, consistent 
with other coronaviruses.2 SARS-CoV-2 has been detected within 48 hours of birth among newborns of 
positive mothers;3,4 however, this may represent horizontal transmission. Early reports indicate that 
SARS-CoV-2-positive neonates usually have mild disease.3,4 Analyses to date suggest that breastmilk is 
unlikely to be a source of infection.5  
 
Guidance regarding care of neonates whose mothers have confirmed or suspected COVID-19 is 
conflicting. The World Health Organization and Royal College of Obstetricians and Gynecologists 
recommend that mothers and newborns room-in and breastfeed, with appropriate precautions, 
emphasizing that the benefits of breastfeeding outweigh potential risks of transmission.6,7 The American 
Academy of Pediatrics advises separation of mothers and newborns from birth, with expressed breastmilk 
feeding by uninfected caregivers until criteria are met.8 In The Lancet Child and Adolescent Health, 
Salvatore and colleagues9 make an important contribution to the literature on management and infection 
control practices for affected mother-newborn dyads.  
 
Salvatore and colleagues9 report the findings of an observational cohort study describing management and 
outcomes of 120 neonates born to 116 (8%) SARS-CoV-2-positive mothers at three hospitals in New 
York City over an 8-week period. All newborns were allowed to room-in with mothers and breastfeed, if 
medically appropriate. Newborns were kept in a closed isolette 6-feet apart, except during feeding. The 
analysis included 82 (69%) newborns who completed follow-up at day 5-7. Sixty-eight (83%) newborns 
roomed-in and 12 (15%) required intensive care admission, 7 (9%) of whom were preterm. Sixty-four 
(78%) newborns were breastfeeding at day 5-7 and 45 (85%) were breastfeeding at 1 month.  
 
The study by Salvatore and colleagues9 highlights several key messages. In particular, it demonstrates that 
rooming-in and breastfeeding are safe when accompanied by mask wearing and frequent hand and breast 
hygiene. It also shows that SARS-CoV-2 transmission to neonates from infected family members is 
unlikely, with proper precautions. No neonates tested positive by nasopharyngeal swab at 12-24 hours, 5-
7 days, or 14 days, and all neonates remained asymptomatic. Forty-seven (60%) mothers were 
asymptomatic at delivery and 20 (26%) were entirely asymptomatic. In another report, 88% of SARS-
CoV-2-positive women were asymptomatic at delivery.10 There was no difference in neonatal outcome 
based on maternal symptom presence.9 The proportion of neonates born preterm was high (14 [17%]) 
compared to the national rate (10%). Several studies have suggested an association between SARS-CoV-2 
in pregnancy and increased risk of preterm birth. In the UK, 26% of SARS-CoV-2-positive women 
delivered preterm.4 In contrast to this cohort in which 13 (93%) preterm births occurred at 32-36 weeks’ 
gestation,9 the UK study reported a notable increase in births at 28-31 weeks’ gestation.11 Rising preterm 
birth rates could pose a significant threat to the health and well-being of children worldwide. 
 
Salvatore and colleagues9 should be commended for undertaking this study while responding to COVID-
19. To date, this is the largest US cohort of neonates born to SARS-CoV-2-positive mothers and 
evaluated with serial testing. The authors acknowledge several limitations, including the sample size, 
follow-up period, and lack of blood, urine, or stool testing. The dynamic state of viral transmission during 
the peak of the pandemic underscores that this study represents a snapshot in time and setting. Thirty-
eight (32%) and 48 (40%) neonates were lost-to-follow-up by days 7 and 14, respectively. Many parents 
were fearful of leaving their homes and using public transportation to attend follow-up, highlighting the 
potential indirect effects of the pandemic on vulnerable populations. COVID-19 outbreaks can rapidly 
overwhelm the capacity of healthcare systems, resulting in disruption of essential services. Estimates 
suggest that an additional 56,700 maternal deaths and 1,157,000 child deaths could result if coverage 
decreases by 45% for 6 months across 118 countries.11 These indirect effects could be more devastating 
for mothers and neonates than COVID-19. 
 
Salvatore and colleagues9 provide valuable data indicating that perinatal SARS-CoV-2 transmission is 
unlikely and allowing newborns to room-in and breastfeed is safe, with appropriate precautions. Despite 
these insights, key questions remain unanswered. Robust population-based data are needed to quantify the 
incidence of complications among pregnant women and neonates, and to understand rates and routes of 
vertical and horizontal transmission, including asymptomatic transmission. Studies are also required to 
determine the effectiveness of infection prevention and control practices in the neonatal care setting. 
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